SCHEMBL5309207

SCHEMBL5309207

COc1ccc(C=Nc2ccc(S(N)(=O)=O)cc2)cc1C

nearest known ligand 0.81

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 18/20 0.81
▸ PTGS1 P23219 9/20 0.77
▸ CA2 P00918 5/20 0.65
▸ CA9 Q16790 4/20 0.65
▸ CA12 O43570 2/20 0.65
▸ CA1 P00915 3/20 0.61
▸ CA7 P43166 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5309203 1.00 PTGS2 (0.81) PTGS2PTGS1CA2CA9CA12
SCHEMBL5309741 0.86 PTGS2 (0.79) PTGS2PTGS1CA2CA9CA12
SCHEMBL5311174 0.86 PTGS2 (0.79) PTGS2PTGS1CA2CA9CA12
SCHEMBL5309745 0.86 PTGS2 (0.79) PTGS2PTGS1CA2CA9CA12
SCHEMBL5311177 0.86 PTGS2 (0.79) PTGS2PTGS1CA2CA9CA12
SCHEMBL5309132 0.85 CA2 (0.71) PTGS2PTGS1CA2CA9CA12
SCHEMBL5309135 0.85 CA2 (0.71) PTGS2PTGS1CA2CA9CA12
SCHEMBL12416806 0.84 PTGS2 (1.00) PTGS2PTGS1CA2CA9CA12
SCHEMBL5308961 0.79 PTGS2 (1.00) PTGS2PTGS1CA2CA9CA12
SCHEMBL5311501 0.79 PTGS2 (1.00) PTGS2PTGS1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799823-B1 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses DAIICHI SANKYO CO LTD (JP) 2007-10-31 — — EP disclosed
US-RE39420-E1 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses SANKYO COMPANY, LIMITED (JP) 2006-12-05 — — US disclosed
US-5908858-A OSTEOPOROSIS; LEUKOTRIENE INHIBITOR SANKYO COMPANY, LIMITED (JP) 1999-06-01 — — US disclosed
EP-0799823-A1 1,2-Diphenylpyrrole derivatives, their preparation and their therapeutic uses SANKYO COMPANY LIMITED (JP) 1997-10-08 — — EP disclosed
Send feedback